Transient exposure to echinacoside is sufficient to activate Trk signaling and protect neuronal cells from rotenone

Journal of Neurochemistry

Volumn 124, Issue 4, 2013, Pages 571-580

  Zhu, Min ^a,b,c   Lu, Chuanzhen ^b,c   Li, Wenwei ^a,b,c  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

echinacoside; MAPKs; neuroprotection; rotenone injury; Trk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CASPASE 3; CYTOCHROME C; ECHINACOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE A; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CISTANCHE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG PENETRATION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLYCOSIDES; HUMANS; HYDROGEN PEROXIDE; INSECTICIDES; L-LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKA; ROTENONE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84873278892     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12103     Document Type: Article

References (23)

1. Chao M. V., (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309.
2. Dago L., Bonde C., Peters D., Moller A., Bomholt S. F., Hartz J. B., Meyer M., Drejer J., and, Gronborg M., (2002) NS 1231, a novel compound with neurotrophic-like effects in vitro and in vivo. J. Neurochem. 81, 17-24.
3. Deng M., Zhao J. Y., Tu P. F., Jiang Y., Li Z. B., and, Wang Y. H., (2004) Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis. Eur. J. Pharmacol. 505, 11-18.
4. Frim D. M., Uhler T. A., Galpern W. R., Beal M. F., Breakefield X. O., and, Isacson O., (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl Acad. Sci. USA 91, 5104-5108.
5. Gao Y., Nikulina E., Mellado W., and, Filbin M. T., (2003) Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J. Neurosci. 23, 11770-11777.
6. Geng X., Tian X., Tu P., and, Pu X., (2007) Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. Eur. J. Pharmacol. 564, 66-74.
7. Kaplan D. R., and, Stephens R. M., (1994) Neurotrophin signal transduction by the Trk receptor. J. Neurobiol. 25, 1404-1417.
8. Kuang R., Sun Y., Yuan W., Lei L., and, Zheng X., (2009) Protective effects of echinacoside, one of the phenylethanoid glycosides, on H(2)O(2)-induced cytotoxicity in PC12 cells. Planta Med. 75, 1499-1504.
9. Martinou J. C., Desagher S., and, Antonsson B., (2000) Cytochrome c release from mitochondria: all or nothing. Nat. Cell Biol. 2, E41-E43.
10. Melo A., Monteiro L., Lima R. M., Oliveira D. M., Cerqueira M. D., and, El-Bacha R. S., (2011) Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev. 2011, 467180.
11. Mufson E. J., Counts S. E., Perez S. E., and, Ginsberg S. D., (2008) Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother, 8, 1703-1718.
12. Ohama T., Hori M., Sato K., Ozaki H., and, Karaki H., (2003) Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J. Biol. Chem. 278, 48794-48804.
13. Pearce R. K., Costa S., Jenner P., and, Marsden C. D., (1999) Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets. J. Neural Transm. 106, 663-683.
14. Perez-Navarro E., Canudas A. M., Akerund P., Alberch J., and, Arenas E., (2000) Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J. Neurochem. 75, 2190-2199.
15. Price R. D., Milne S. A., Sharkey J., and, Matsuoka N., (2007) Advances in small molecules promoting neurotrophic function. Pharmacol. Ther. 115, 292-306.
16. Ramsay R. R., Krueger M. J., Youngster S. K., Gluck M. R., Casida J. E., and, Singer T. P., (1991) Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J. Neurochem. 56, 1184-1190.
17. Saragovi H. U., and, Gehring K., (2000) Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol. Sci. 21, 93-98.
18. Webster N. J., and, Pirrung M. C., (2008) Small molecule activators of the Trk receptors for neuroprotection. BMC Neurosci. 9 (Suppl 2), S1.
19. Wei L., Chen H., Jiang Y., Tu P., Zhong M., Liu F., and, Liu C., (2011) Determination of ECH on cerebral ischemia injury rat plasma and brain tissue by HPLC method. Chin. Pharm. Bull. 27, 737-738. (article in Chinese)
20. Wu Y., Li L., Wen T., and, Li Y. Q., (2007) Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats. Toxicology 232, 50-56.
21. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., and, Wang X., (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
22. Zhang Y., Xing J., Ai T., Wen T., Guan L., and, Zhao J., (2007) Protection of echinacoside against acute lung injury caused by oleic acid in rats. Free Radic. Res. 41, 798-805.
23. Zhao Q., Gao J., Li W., and, Cai D., (2010) Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease. Brain Res. 1346, 224-236.